Mochida Pharmaceutical Co Ltd
TSE:4534
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mochida Pharmaceutical Co Ltd
TSE:4534
|
JP |
|
Yamada Consulting Group Co Ltd
TSE:4792
|
JP |
|
A
|
Axon Partners Group SA
F:XE1
|
ES |
|
Cordoba Minerals Corp
F:7C6A
|
CA |
|
S
|
Sarine Technologies Ltd
OTC:SILLF
|
IL |
|
Employers Holdings Inc
F:YGB
|
US |
|
Omai Gold Mines Corp
F:0N2
|
CA |
|
B
|
BFF Bank SpA
SWB:2BF
|
IT |
|
P
|
PCF Group PLC
XBER:RLW
|
UK |
|
S
|
Societe Pour l Informatique Industrielle SA
LSE:0MVM
|
FR |
|
Fortis Frontier PLC
F:0I10
|
UK |
|
New Break Resources Ltd
OTC:NBRKF
|
CA |
|
S
|
Sanu Gold Corp
F:L73
|
CA |
|
Sopheon PLC
F:TXB3
|
UK |
|
Nippon Shinyaku Co Ltd
OTC:NPNKF
|
JP |
|
Q
|
Quantum eMotion Corp
AMEX:QNC
|
CA |
|
C
|
Christina Lake Cannabis Corp
F:CLB
|
CA |
|
Abo-Group Environment NV
F:3T61
|
BE |
|
S
|
Sparton Resources Inc
OTC:SPNRF
|
CA |
|
FTC Solar Inc
F:6YK
|
US |
|
H
|
Haemonetics Corp
XMUN:HAZ
|
US |
|
A
|
Acadia Healthcare Company Inc
F:7RA
|
US |
|
N
|
NEXE Innovations Inc
OTC:NEXNF
|
CA |
|
E
|
Evixar Inc
TSE:4257
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Mochida Pharmaceutical Co Ltd's stock price target?
Not Available
Mochida Pharmaceutical Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Mochida Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 1 year is -5%.
What is the Gross Profit forecast for Mochida Pharmaceutical Co Ltd?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 2 years is -3%.
What is the Pre-Tax Income forecast for Mochida Pharmaceutical Co Ltd?
Projected CAGR
-28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 2 years is -28%.
What is the Net Income forecast for Mochida Pharmaceutical Co Ltd?
Projected CAGR
-25%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 2 years is -25%.
